KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) EBIT (2019 - 2025)

Clover Health Investments (CLOV) has disclosed EBIT for 7 consecutive years, with $41.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT rose 294.11% year-over-year to $41.6 million, compared with a TTM value of $5.4 million through Dec 2025, up 111.85%, and an annual FY2025 reading of $323.1 million, up 806.3% over the prior year.
  • EBIT was $41.6 million for Q4 2025 at Clover Health Investments, up from -$24.4 million in the prior quarter.
  • Across five years, EBIT topped out at $41.6 million in Q4 2025 and bottomed at -$186.8 million in Q4 2021.
  • Average EBIT over 5 years is -$62.7 million, with a median of -$41.5 million recorded in 2023.
  • The sharpest move saw EBIT plummeted 150434.31% in 2021, then soared 294.11% in 2025.
  • Year by year, EBIT stood at -$186.8 million in 2021, then surged by 42.92% to -$106.6 million in 2022, then soared by 61.11% to -$41.5 million in 2023, then surged by 48.28% to -$21.4 million in 2024, then skyrocketed by 294.11% to $41.6 million in 2025.
  • Business Quant data shows EBIT for CLOV at $41.6 million in Q4 2025, -$24.4 million in Q3 2025, and -$10.6 million in Q2 2025.